Henoch-Schönlein purpura

Area of Science:

• Immunology
• Pediatrics
• Rheumatology

Background:

• Henoch-Schönlein purpura (HSP) is a common childhood vasculitis characterized by immunoglobulin A deposition.
• It typically affects the skin, joints, gastrointestinal tract, and kidneys, often presenting with a distinctive rash on the lower extremities and buttocks.
• Diagnosis in children is usually clinical, but skin biopsy may be necessary in atypical cases, including adults and very young children.

Purpose of the Study:

• To summarize the clinical presentation, diagnostic considerations, treatment modalities, and prognosis of Henoch-Schönlein purpura.
• To highlight the role of corticosteroids in managing severe HSP manifestations.
• To underscore the importance of monitoring for renal and neurological involvement due to potential long-term morbidity.

Main Methods:

• Review of existing literature on Henoch-Schönlein purpura, including retrospective studies and clinical experience.
• Analysis of diagnostic criteria and the utility of skin biopsy in different age groups.
• Evaluation of treatment strategies for various HSP involvements and their supporting evidence.

Main Results:

• HSP commonly affects children aged 3-10 years with a characteristic rash distribution, making biopsy often unnecessary in this group.
• Skin biopsy is frequently required for diagnosis in adults and very young children due to atypical rash presentation.
• Steroids are supported by retrospective data for severe gastrointestinal, renal, central nervous system, and testicular involvement.

Conclusions:

• While HSP generally has a self-limited course and excellent prognosis, severe renal and neurological complications can lead to significant long-term morbidity.
• Recurrences are common, occurring within weeks to several years after the initial episode.
• Aggressive management with steroids, and potentially immunosuppressive agents or plasmapheresis for severe cases, is crucial for improving outcomes.